NOOR, M. HAMZA, et al. “Open-Label Randomized Trial of High-Dose Rifampicin to Shorten Treatment for Drug-Sensitive Pulmonary TB (Hi-Dori-3)”. Annals of Pakistan Medical & Allied Professionals, vol. 1, no. 7, October, Oct. 2025, pp. 7-11, doi:10.53350/Annalspakmed.1.7.7.